Skip to main content
Clinical Trials/NCT04682054
NCT04682054UnknownNot Applicable

Molecular Taxonomy of Surgically-harvested Ocular Tissues Defined by Single-cell Transcriptomics

The First Affiliated Hospital with Nanjing Medical University1 site in 1 country80 target enrollmentStarted: January 15, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
80
Locations
1
Primary Endpoint
counts of each cell type

Study Overview

Brief Summary

The surgically-harvested eye tissue (ie. vitreous-retinal proliferative membrane, outflow pathway, retinas, and pterygium) is a complex tissue responsible for maintaining intraocular homeostasis or mediating ocular pathogenesis. Dysfunction of one or more resident cell types within the tissues results in different ocular disorder, leading to vision loss, or even blindness. In this study, we aim to use single-cell RNA sequencing to generate a comprehensive cell atlas of surgically-harvested eye tissues.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
18 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with ocular diseases and require surgery intervention.
  • The surgery intervention remove pathological tissue during surgery.
  • Patients consent to the treatment and single-cell sequencing.

Exclusion Criteria

  • Surgically removed eye tissue cannot meet with the quality control of single-cell sequencing (mainly the tissue weight and cell counts);

Outcomes

Primary Outcomes

counts of each cell type

Time Frame: 1 month

single-cell sequencing identify what cells and the counts within the eye tissue

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials